Valuation : Norda ASA

Market Cap 513M 55.19M 47.49M 44.68M 40.82M 76.36M 5.21B 76.56M 528M 205M 2.67B 207M 203M 8.61B P/E 2023 *
-
P/E 2024 3.26x
Enterprise Value 264M 28.43M 24.46M 23.02M 21.03M 39.33M 2.68B 39.44M 272M 106M 1.38B 107M 104M 4.44B EV / Sales 2023
-1.24x
EV / Sales 2024 0.4x
Free-Float
6.26%
Yield 2023 *
-
Yield 2024 32.5%
1 day+0.12%
1 week+0.12%
Current month+0.12%
1 month-1.50%
3 months-1.50%
Current year-14.90%
1 week 85.1
Extreme 85.1
85.1
1 month 85
Extreme 85
85.1
Current year 81
Extreme 81
86.4
1 year 81
Extreme 81
100
3 years 41
Extreme 41
100
5 years 41
Extreme 41
100
10 years 8
Extreme 8
100
Manager TitleAgeSince
Chief Executive Officer - 2013-04-07
Director TitleAgeSince
Chairman 54 2014-01-30
Director/Board Member 68 2013-06-19
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%+0.12%+5.06%+107.56% 46.97M
-1.08%-2.81%-1.72%+13.81% 48.93B
-0.40%+1.03%+418.57%+527.30% 45.01B
-1.42%+2.30%+42.67%+22.37% 44.07B
-1.22%-2.31%+4.82%+77.49% 40.73B
+0.53%-1.36%+16.87%+46.82% 33.52B
-0.21%+9.14% - - 17.77B
-0.35%-1.56%+21.42%+120.75% 16.5B
-1.21%-0.96%+12.39%+31.58% 14.67B
-1.65%-1.03%+75.93%+41.12% 13.77B
Average -0.69%+0.48%+66.22%+109.87% 27.5B
Weighted average by Cap. -0.78%+0.11%+89.33%+128.86%

Financials

2023 2024
Net sales 86.92M 9.35M 8.04M 7.57M 6.91M 12.93M 883M 12.97M 89.43M 34.7M 453M 35.1M 34.34M 1.46B 372M 39.99M 34.41M 32.38M 29.58M 55.33M 3.78B 55.48M 383M 148M 1.94B 150M 147M 6.24B
Net income 31.17M 3.35M 2.88M 2.71M 2.48M 4.64M 317M 4.65M 32.07M 12.45M 162M 12.59M 12.31M 523M 126M 13.54M 11.66M 10.97M 10.02M 18.74M 1.28B 18.79M 130M 50.28M 656M 50.86M 49.75M 2.11B
Net Debt -311M -33.47M -28.8M -27.1M -24.76M -46.31M -3.16B -46.44M -320M -124M -1.62B -126M -123M -5.22B -249M -26.76M -23.03M -21.66M -19.79M -37.02M -2.53B -37.12M -256M -99.34M -1.3B -100M -98.29M -4.18B
Logo Norda ASA
Norda ASA, formerly NorDiag ASA, is a Norway-based company active within the biotechnology sector. It develops, manufactures and markets automated solutions (instruments and tests) for sample preparation of bacterial and human DNA from difficult biological samples for use in the fields of infectious diseases, transplantation testing (HLA Typing) and others. The Company’s products include NorDiag Arrow (CE, IVD), which is a compact, automated solution for nucleic acid extractions, as well as NorDiag Bullet, 8 tip config, which is a fully automated sample preparation instrument for molecular diagnostics and can isolate from samples such as urine, swab, faces, sputum and blood. Its distribution products include Molzym GmbH and Co KG, as well as Hain Lifescience GmbH. Its customers are clinical laboratories, hospitals, research institutes, medical diagnostics and healthcare providers. It is operational through offices and laboratories in Norway, Sweden, Austria and the United States.
Employees
1
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. NORD Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!